BAKER BROS. ADVISORS LP
Q1 2024 13F-HR Holdings
Net value change ($000)
-816,894
(-9.3%)
New positions
13
Sold out positions
8
Turnover %
4.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| RVMD | 95,649 | 64.8% |
| BCYC | 90,706 | 280.2% |
| KYMR | 88,380 | 57.9% |
| EWTX | 72,469 | 212.8% |
| MDGL | 70,243 | 15.4% |
| KOD | 38,429 | 73.0% |
| STOK | 34,795 | 325.8% |
| CELC | 25,732 | 329.8% |
| DNLI | 20,624 | 36.9% |
| NRIX | 17,003 | 42.4% |
Top Reduces (Value $000, Stocks/ETFs)
| ACAD | -549,524 | -40.9% |
| ONC | -253,336 | -13.3% |
| Mirati Therapeutics, Inc. | -242,135 | -100.0% |
| INCY | -210,531 | -9.3% |
| IMCR | -73,720 | -42.8% |
| Gracell Biotechnologies Inc. | -20,883 | -100.0% |
| RYTM | -16,892 | -5.7% |
| DAWN | -14,600 | -100.0% |
| SPRY | -10,995 | -100.0% |
| BCRX | -9,215 | -15.2% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|